** Shares of telehealth firm Hims and Hers HIMS.N rise 16.1% to $67.94
** Co acquires at-home lab testing service Trybe Labs, which offers at-home blood draws and whole body testing for subscribers
** With at-home lab testing, customers will be able to access more information about their health and providers can recommend high-quality customized treatments - HIMS
** HIMS expects to roll out at-home testing over the next year
** HIMS funded the acquisition through cash on hand
** "All-in, our general view is that we need to hear more. Seeing a category expansion, or in this case service expansion, is not a surprise on the surface" - brokerage Leerink Partners
** Stock has risen 6x in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。